At the upcoming committee meeting, the PCAC, an FDA committee that provides expert advice on scientific, technical, and medical issues regarding drug compounding under sections 503A and 503B, will consider whether to recommend certain substances for inclusion in the 503A bulks list
This is especially important with research peptides, where online content often makes stronger claims than the clinical evidence supports
10.2174/092986712803414015 [DOI] [PubMed] [Google Scholar] Sikiric P., Seiwerth S., Rucman R., Turkovic B., Rokotov D
Treatment should be directed at the cause: moisturising the nail folds, avoiding repeated trauma from harsh manicures, checking for fungal infections when indicated, and correcting deficiencies when present